InMed Pharmaceuticals logo

InMed Pharmaceuticals

INMNASDAQ

InMed Pharmaceuticals is a biotechnology company in the healthcare sector on NASDAQ, led by Eric A. Adams, with a market cap of $4.0M. As of Q3 2025, 13% of shares are held by 7 institutional investors, with SABBY MANAGEMENT, LLC as the largest holder at 9.23%.

CEOEric A. Adams
Market Cap$4.0M
Biotechnology
Healthcare
Employees13.0
Country
United States of America

Overview

Overview of institutional ownership in INM as of Q3 2025 with a market cap of $5.2M

All Institutions

Institutions
7
Value Held
$664.8K
Shares Held
303.6K
Avg Position
$95.0K
Median Position
$36.8K

Hedge Funds

Hedge Funds
1
Value Held
$36.8K
Shares Held
16.8K
Avg Position
$36.8K
Median Position
$36.8K

Ownership Breakdown

Institutional (non-HF): 12.03%Institutional (non-HF)Hedge Funds: 0.70%Retail & Other: 87.27%Retail & Other
Institutional (non-HF)
12.03%
$628.1K
Hedge Funds
0.705%
$36.8K
Retail & Other
87.27%
$4.6M

Based on market cap of $5.2M as of Q3 2025. Institutional (non-HF) excludes hedge funds to avoid double counting.

Biggest Investors

Institutions with the largest positions in INM as of Q3 2025

InstitutionPosition Value
$481.8K
2.62% of portfolio
$78.5K
0.00% of portfolio
$44.6K
0.00% of portfolio
$36.8K
0.00% of portfolio
$22.4K
0.01% of portfolio
$657.0
0.00% of portfolio
$4.0
0.00% of portfolio
B
-
0.00% of portfolio
UBS Group AG logo
UBS Group AG
Institution
-
0.00% of portfolio
-
0.00% of portfolio

Net Capital Flow

Institutional buying and selling activity for INM in Q3 2025

Traded
+$637.7K
Buyers
6
Sellers
2
Total Bought
+$664.2K
Total Sold
$26.5K
Avg Position
$60.4K

Biggest Buyers

InstitutionNet Bought
+$481.8K
+220.0K shares
+$78.5K
+35.9K shares
+$44.6K
+20.4K shares
+$36.8K
+16.8K shares
+$22.4K
+10.2K shares
+$2.0
+1.0 shares

Biggest Sellers

InstitutionNet Sold
UBS Group AG logo
UBS Group AG
Institution
$25.2K
7.8K shares
$1.3K
400.0 shares

Entry and Exit Activity

Institutions that initiated new positions or completely exited INM in Q3 2025

New Positions
2
New Value
$101.0K
Exited Positions
3
Exited Value
$26.5K

New Positions

InstitutionPosition Value
$78.5K
35.9K shares
$22.4K
10.2K shares

Exited Positions

InstitutionPrevious Position
UBS Group AG logo
UBS Group AG
Institution
$25.2K
7.8K shares
$1.3K
400.0 shares
B
-
1.0 shares

Options Activity

Institutions with the largest Call and Put options positions in INM as of Q3 2025

Call Positions
0
Call Value
-
Put Positions
0
Put Value
-

Call Positions

InstitutionPosition Value
No call positions found

Put Positions

InstitutionPosition Value
No put positions found

Most Committed Institutions

Institutions with INM as the highest % of their portfolio as of Q3 2025

InstitutionPortfolio Weight
2.62%
$481.8K
0.01%
$22.4K
0.00%
$78.5K
0.00%
$44.6K
0.00%
$36.8K
0.00%
$657.0
0.00%
$4.0
B
0.00%
-
UBS Group AG logo
UBS Group AG
Institution
0.00%
-
0.00%
-

Hedge Fund Spotlight

Discover hedge funds investing in INM

RENAISSANCE TECHNOLOGIES LLC logo
RENAISSANCE TECHNOLOGIES LLC
Hedge FundQuant
Portfolio ManagerPeter Fitzhugh Brown
Portfolio Value
$75.8B
Positions
3,419
Last Reported
Q3 2025
AddressNew York, NY
Sector Allocation
Technology: 23.40%TechnologyHealthcare: 13.00%HealthcareConsumer Cyclical: 10.00%Consumer CyclicalFinancial Services: 8.00%Industrials: 7.70%Communication Services: 7.30%Consumer Defensive: 6.00%Basic Materials: 4.40%Energy: 3.70%ETF: 2.80%Real Estate: 2.50%Utilities: 2.10%
InMed Pharmaceuticals logo

Position in InMed Pharmaceuticals

Market Value
$36.8K
Shares Held
16.8K
Portfolio Weight
0.00%
Owned Since
2025-Q3
Top HoldingSectorMarket ValueWeight
Software - Infrastructure
Technology
$1.6B2.06%
2
Nvidia logo
Nvidia
NVDA
Semiconductors
Technology
$1.1B1.39%
3
Roblox logo
Roblox
RBLX
Electronic Gaming & Multimedia
Technology
$953.5M1.26%

Cookie Preferences

We use cookies for analytics. See our Privacy and Cookie Policy.